Company / Capital Expenditures
Bausch & Lomb Corp Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$349.0M
FY2025
5-year range
$175.0M / $349.0M
FY2021-FY2025
Trend
+19.9%
vs FY2024
Sector context
#33 of 145
Health Care
What the data says
Bausch & Lomb Corp's capital expenditures of $349M is higher than 77% of companies in the Health Care sector (FY2025). Capital Expenditures has increased for 3 consecutive years, from $175M in FY2022 to $349M in FY2025.
Based on SEC 10-K filings.
$349M in FY2025 with a 5-year CAGR of +6.6%. Top quartile in the Health Care sector.
Improved from $181M to $349M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +25.9%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Sector benchmark
+30.0% above sector average
Key checks
Key Insights
- Bausch & Lomb Corp's capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of +6.6%, indicating consistent growth.
- In FY2025, capital expenditures increased 19.9% year-over-year.
- Ranks #33 out of 145 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $349.0M | +19.9% |
| FY2024 | $291.0M | +60.8% |
| FY2023 | $181.0M | +3.4% |
| FY2022 | $175.0M | -9.3% |
| FY2021 | $193.0M | -23.7% |
| FY2020 | $253.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026